Shida et al., 2017 - Google Patents
HIV‐1 susceptibility of transgenic rat‐derived primary macrophage/T cells and a T cell line that express human receptors, CyclinT1 and CRM 1 genesShida et al., 2017
View PDF- Document ID
- 9678374769078751956
- Author
- Shida H
- Okada H
- Suzuki H
- Zhang X
- Chen J
- Tsunetsugu‐Yokota Y
- Tanaka Y
- Yakushiji F
- Hayashi Y
- Publication year
- Publication venue
- Genes to Cells
External Links
Snippet
We developed transgenic (Tg) rats that express human CD 4, CCR 5, CXCR 4, CyclinT1, and CRM 1 genes. Tg rat macrophages were efficiently infected with HIV‐1 and supported production of infectious progeny virus. By contrast, both rat primary CD 4+ T cells and …
- 241000700159 Rattus 0 title abstract description 142
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection | |
Fackler et al. | Functional characterization of HIV-1 Nef mutants in the context of viral infection | |
Ohainle et al. | TRIM34 restricts HIV-1 and SIV capsids in a TRIM5α-dependent manner | |
Bego et al. | Vpu exploits the cross-talk between BST2 and the ILT7 receptor to suppress anti-HIV-1 responses by plasmacytoid dendritic cells | |
BR112019018288A2 (en) | METHODS AND COMPOSITIONS FOR TRANSDUCING AND EXPANDING LYMPHOCYTES AND REGULATING THE SAME ACTIVITY | |
Goffinet et al. | Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses | |
Iafrate et al. | Disrupting surfaces of nef required for downregulation of CD4 and for enhancement of virion infectivity attenuates simian immunodeficiency virus replication in vivo | |
Schmitz et al. | Lv2, a novel postentry restriction, is mediated by both capsid and envelope | |
Lemaître et al. | The HERV-K human endogenous retrovirus envelope protein antagonizes Tetherin antiviral activity | |
Jin et al. | Natural HIV-1 Nef polymorphisms impair SERINC5 downregulation activity | |
Roesch et al. | A CRISPR screen for factors regulating SAMHD1 degradation identifies IFITMs as potent inhibitors of lentiviral particle delivery | |
Anthony-Gonda et al. | In vivo killing of primary HIV-infected cells by peripheral-injected early memory–enriched anti-HIV duoCAR T cells | |
Chakrabarti et al. | A truncated form of Nef selected during pathogenic reversion of simian immunodeficiency virus SIVmac239Δnef increases viral replication | |
Wetzel et al. | Loss of CXCR6 coreceptor usage characterizes pathogenic lentiviruses | |
Misra et al. | Macaques as model hosts for studies of HIV-1 infection | |
Keppler et al. | Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef | |
Mehmetoglu-Gurbuz et al. | Combination gene therapy for HIV using a conditional suicidal gene with CCR5 knockout | |
Mesner et al. | Loss of Nef-mediated CD3 down-regulation in the HIV-1 lineage increases viral infectivity and spread | |
Mühlebach et al. | Stable transduction of primary human monocytes by simian lentiviral vector PBj | |
Zhang et al. | A novel, fully spliced, accessory gene in equine lentivirus with distinct rev-responsive element | |
Mautino et al. | Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense | |
Reuter et al. | Role of HIV-2 envelope in Lv2-mediated restriction | |
Shida et al. | HIV‐1 susceptibility of transgenic rat‐derived primary macrophage/T cells and a T cell line that express human receptors, CyclinT1 and CRM 1 genes | |
Wu et al. | TRIM5α resistance escape mutations in the capsid are transferable between simian immunodeficiency virus strains | |
Jain et al. | African Green Monkey TRIM5α Restriction in Simian Immunodeficiency Virus-Specific Rhesus Macaque Effector CD4 T Cells Enhances Their Survival and Antiviral Function |